Trial Outcomes & Findings for Effect of a Patient-Centered Decision App on TOLAC (NCT NCT02646423)
NCT ID: NCT02646423
Last Updated: 2021-02-02
Results Overview
Number of participants who underwent a trial of labor after cesarean (TOLAC) delivery, as noted in the medical record.
COMPLETED
NA
1485 participants
0-8 weeks after delivery
2021-02-02
Participant Flow
Participant milestones
| Measure |
Prior CD Decision App (PCDDA)
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Overall Study
STARTED
|
742
|
743
|
|
Overall Study
COMPLETED
|
735
|
735
|
|
Overall Study
NOT COMPLETED
|
7
|
8
|
Reasons for withdrawal
| Measure |
Prior CD Decision App (PCDDA)
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Overall Study
Adverse Event
|
5
|
7
|
|
Overall Study
Ineligible
|
2
|
1
|
Baseline Characteristics
Effect of a Patient-Centered Decision App on TOLAC
Baseline characteristics by cohort
| Measure |
Prior CD Decision App (PCDDA)
n=735 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=735 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
Total
n=1470 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
34.1 years
STANDARD_DEVIATION 4.6 • n=5 Participants
|
34.0 years
STANDARD_DEVIATION 4.5 • n=7 Participants
|
34.0 years
STANDARD_DEVIATION 4.5 • n=5 Participants
|
|
Sex: Female, Male
Female
|
735 Participants
n=5 Participants
|
735 Participants
n=7 Participants
|
1470 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race or ethnic group · White
|
394 Participants
n=5 Participants
|
411 Participants
n=7 Participants
|
805 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race or ethnic group · Latina
|
124 Participants
n=5 Participants
|
124 Participants
n=7 Participants
|
248 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race or ethnic group · Asian or Pacific Islander
|
110 Participants
n=5 Participants
|
106 Participants
n=7 Participants
|
216 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race or ethnic group · Black
|
64 Participants
n=5 Participants
|
52 Participants
n=7 Participants
|
116 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race or ethnic group · Biracial or multiracial/multiethnic
|
23 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
48 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Race or ethnic group · Other
|
20 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
37 Participants
n=5 Participants
|
|
Region of Enrollment
United States · University of California, San Francisco
|
192 Participants
n=5 Participants
|
193 Participants
n=7 Participants
|
385 Participants
n=5 Participants
|
|
Region of Enrollment
United States · Marin Community Clinic, San Rafael, California
|
26 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
|
Region of Enrollment
United States · St Luke's Women's Clinic, San Francisco
|
18 Participants
n=5 Participants
|
18 Participants
n=7 Participants
|
36 Participants
n=5 Participants
|
|
Region of Enrollment
United States · Massachusetts General Hospital, Boston
|
274 Participants
n=5 Participants
|
278 Participants
n=7 Participants
|
552 Participants
n=5 Participants
|
|
Region of Enrollment
United States · Northwestern University Medical Center, Chicago
|
225 Participants
n=5 Participants
|
221 Participants
n=7 Participants
|
446 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 0-8 weeks after deliveryPopulation: Prior CD Decision App (PCDDA): no data available for N=8 participants who delivered at outside institution and no chart or outside questionnaire obtained. Usual Care - No App: no data available for N=3 participants who delivered at outside institution and no chart or outside questionnaire obtained.
Number of participants who underwent a trial of labor after cesarean (TOLAC) delivery, as noted in the medical record.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=727 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=732 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Number of Participants Who Underwent a Trial of Labor After Cesarean (TOLAC) Delivery
|
315 Participants
|
338 Participants
|
SECONDARY outcome
Timeframe: 0 to 8 weeks after deliveryPopulation: Prior CD Decision App (PCDDA): no data available for N=8 participants who delivered at outside institution and no chart or outside questionnaire obtained. Usual Care - No App: no data available for N=3 participants who delivered at outside institution and no chart or outside questionnaire obtained.
Number of participants who underwent vaginal birth after cesarean (VBAC), as noted in the medical record.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=727 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=732 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Number of Participants Who Underwent Vaginal Birth After Cesarean (VBAC)
|
231 Participants
|
233 Participants
|
SECONDARY outcome
Timeframe: Approx 34-37 weeks gestationPopulation: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained, 31 Could not be reached for follow-up, 26 Delivered prior to follow-up interview, 2 Had pregnancy loss ≥22 wk. Usual Care - No App: 681 Follow-up telephone interviews obtained, 31 Could not be reached for follow-up, 23 Delivered prior to follow-up interview.
8-item knowledge scale, administered during telephone interview. Scores ranged from 0 to 8 with higher scored indicating greater knowledge.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=676 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=681 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Knowledge About TOLAC and ERCD
|
5.0 score on a scale
Standard Deviation 1.8
|
5.0 score on a scale
Standard Deviation 1.7
|
SECONDARY outcome
Timeframe: Approx 34-37 weeks gestationPopulation: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Conflict Scale missing for 5 participants with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Conflict Scale missing for 6 participants with usual care.
16-item Decisional Conflict Scale with 5 response categories, administered during telephone interview. Scoring: total scale-0 (no decisional conflict) to 100 (extreme decisional conflict) lower values indicate lower decisional conflict.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=671 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=675 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Decisional Conflict
|
17.2 score on a scale
Standard Deviation 12.9
|
17.5 score on a scale
Standard Deviation 13.9
|
SECONDARY outcome
Timeframe: Approx 34-37 weeks gestationPopulation: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Shared Decision Making Scale missing for 12 participants with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Shared Decision Making Scale missing for 9 participants with usual care.
9-item Shared Decision Making Scale, administered during telephone interview. Shared decision-making was measured using the 9-item Shared Decision Making Questionnaire (SDM-Q-9), a psychometrically evaluated tool. The core instrument consists of nine statements, which can be rated on a six-point scale from "completely disagree" (0) to "completely agree" (5). The Shared Decision Score can range from 0 to 100, with higher scores indicating more shared decision-making.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=664 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=672 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Shared Decision Making
|
74.4 score on a scale
Standard Deviation 14.9
|
74.8 score on a scale
Standard Deviation 15.9
|
SECONDARY outcome
Timeframe: Approx 34-37 weeks gestationPopulation: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Self-Efficacy Scale missing for 6 participants with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Self-Efficacy Scale missing for 9 participants with PCDAA.
11-item Decisional Self-Efficacy Scale, administered during telephone interview. The total score is calculated by summing the 11 items, dividing by 11 and multiplying by 25. Scores range from 0 (not confident) to 100 (extremely confident).
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=670 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=672 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Decision Self-Efficacy
|
90.7 score on a scale
Standard Deviation 12.3
|
90.3 score on a scale
Standard Deviation 12.2
|
SECONDARY outcome
Timeframe: Approx 34-37 weeks gestationPopulation: Prior CD Decision App (PCDDA): 676 Follow-up telephone interviews obtained. Responses on the Decisional Satisfaction Scale missing for 1 participant with PCDAA. Usual Care-No App: 681 Follow-up interviews obtained. Responses on the Decisional Satisfaction Scale missing for 2 participants with PCDAA.
6-item Satisfaction with Decision Scale, administered during telephone interview. Satisfaction With Decision Scale scores range from 0 to 5, with higher scores indicating more satisfaction.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=675 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=679 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Decision Satisfaction
|
4.62 score on a scale
Standard Deviation 0.59
|
4.65 score on a scale
Standard Deviation 0.54
|
SECONDARY outcome
Timeframe: Collected 0 to 8 weeks after delivery.Population: PCDDA: 15 delivered at outside institution and outcome for maternal major morbidity was not obtained. Usual Care- No app: 12 delivered at outside institution and outcome for maternal major morbidity was not obtained.
Defined as any of: uterine rupture, hysterectomy, surgical injury (bowel, bladder/ureter, or other), maternal death, as noted in the medical record for her delivery.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=723 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Maternal Major Morbidity
|
19 Participants
|
23 Participants
|
SECONDARY outcome
Timeframe: Collected 0 to 8 weeks after delivery.Population: PCDDA: 15 Delivered at outside institution and maternal minor morbidity outcome not collected during chart review. 1 additional without complete chart review information. No App: 12 Delivered at outside institution and maternal minor morbidity outcome not collected during chart review. 1 additional without complete chart review information.
Defined as any of: blood transfusion, postpartum febrile morbidity (endometritis, cellulitis, urinary tract infection, or other infection), as noted in the medical record for her delivery.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=719 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=722 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Maternal Minor Morbidity
|
36 Participants
|
36 Participants
|
SECONDARY outcome
Timeframe: Collected 0 to 8 weeks after delivery.Population: PCDDA: 15 delivered at outside institution and outcome for 3rd or 4th degree lacerations was not obtained. Usual Care- No app: 12 delivered at outside institution and outcome for 3rd or 4th degree lacerations was not obtained.
3rd or 4th degree lacerations, as noted in the medical record for her delivery.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=723 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
3rd or 4th Degree Lacerations
|
16 Participants
|
12 Participants
|
SECONDARY outcome
Timeframe: Collected 0 to 8 weeks after delivery.Population: PCDDA: 15 delivered at outside institution and outcome for perinatal death or hypoxic-ischemic encephalopathy was not obtained from chart review. No app: 12 delivered at outside institution and outcome for perinatal death or hypoxic-ischemic encephalopathy was not obtained from chart review. 1 delivery at institution missing outcome from chart.
Stillbirth/fetal demise (antepartum or intrapartum), neonatal death, HIE, as noted in the medical record for her delivery.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=722 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Perinatal Death or Hypoxic-ischemic Encephalopathy
Neonatal death
|
2 participants
|
0 participants
|
|
Perinatal Death or Hypoxic-ischemic Encephalopathy
Intrauterine fetal demised
|
4 participants
|
0 participants
|
|
Perinatal Death or Hypoxic-ischemic Encephalopathy
Hypoxic-ischemic encephalopathy
|
2 participants
|
4 participants
|
SECONDARY outcome
Timeframe: Collected 0 to 8 weeks after delivery.Population: PCDDA: 15 delivered at outside institution and neonatal respiratory morbidity was not obtained from chart review. 1 delivery at institution missing outcome from chart. No app: 12 delivered at outside institution and neonatal respiratory morbidity was not obtained from chart review. 2 deliveries at institution missing outcome from chart.
Respiratory morbidity requiring CPAP or intubation, as noted in the medical record for her delivery.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=719 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=721 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Neonatal Respiratory Morbidity
|
67 Participants
|
68 Participants
|
SECONDARY outcome
Timeframe: Collected 0 to 8 weeks after delivery.Population: Prior CD Decision App (PCDDA): 15 delivered at outside institution and NICU admission was not obtained from chart review. Usual Care-No app: 12 delivered at outside institution and NICU admission was not obtained from chart review. 1 delivery at institution missing outcome from chart.
Neonatal intensive care unit (NICU) admission, as noted in the medical record for her delivery.
Outcome measures
| Measure |
Prior CD Decision App (PCDDA)
n=720 Participants
Women who are randomized to PCDDA will be provided access to a tablet which they can use to view the Prior CD Decision App at their own pace. The research assistant will print a summary of the participant's predicted likelihood of a vaginal delivery (VBAC) if she undergoes a trial of labor (TOLAC), as well as her answers to the values clarification exercises, that she can review and share with whomever she chooses, including her provider.
|
Usual Care - No App
n=722 Participants
Women randomized to the Usual Care - No App group will simply continue with usual care.
|
|---|---|---|
|
Neonatal Intensive Care Unit (NICU) Admission
|
98 Participants
|
87 Participants
|
Adverse Events
Prior CD Decision App (PCDDA)
Usual Care - No App
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Miriam Kupperman, PhD, MPH
University of California, San Francisco
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place